Skip to content

Opening book details…

About this Medicine article

Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease by Yacyshyn, Bruce; Ginsberg, Daniel C.; Gilder, Kye; Walsh, Brandon; English, Brett; Turner, Stewart A.; Klassen, Preston; Hanauer, Stephen B.; Barish, Charles F.; Higgins, Peter D. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Yacyshyn, Bruce; Ginsberg, Daniel C.; Gilder, Kye; Walsh, Brandon; English, Brett; Turner, Stewart A.; Klassen, Preston; Hanauer, Stephen B.; Barish, Charles F.; Higgins, Peter D.
Publisher
Elsevier Science; Elsevier ; W. B. Saunders Co., Ltd.; Elsevier BV (ISSN 0016-5085)
Published
2019
Language
EN
Field
Medicine (Health Sciences)

More by Yacyshyn, Bruce; Ginsberg, Daniel C.; Gilder, Kye; Walsh, Brandon; English, Brett; Turner, Stewart A.; Klassen, Preston; Hanauer, Stephen B.; Barish, Charles F.; Higgins, Peter D.

Browse all works by Yacyshyn, Bruce; Ginsberg, Daniel C.; Gilder, Kye; Walsh, Brandon; English, Brett; Turner, Stewart A.; Klassen, Preston; Hanauer, Stephen B.; Barish, Charles F.; Higgins, Peter D.